Cytochrome P450 polymorphisms are associated with reduced warfarin dose

This publication has 22 references indexed in Scilit:

• Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
  The Lancet, 1999
• Microchip Arrays Put DNA on the Spot
  Science, 1998
• The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis
  New England Journal of Medicine, 1998
• Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?
  The Lancet, 1997
• Allelic and functional variability of cytochrome P4502C9
  Pharmacogenetics, 1997
• The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
  Pharmacogenetics, 1996
• Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
  Pharmacogenetics, 1995
• Interactions of Warfarin with Drugs and Food
  Annals of Internal Medicine, 1994
• Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
  The American Journal of Medicine, 1993
• Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
  Annals of Internal Medicine, 1993